Department of Dermatology, University of Minnesota, Minneapolis.
Department of Dermatology, Minneapolis VA Medical Center, Minneapolis, Minnesota.
JAMA Dermatol. 2024 Sep 1;160(9):977-983. doi: 10.1001/jamadermatol.2024.2097.
Sexual minority (SM) persons have been found to have differential rates of skin cancer, but limited data exist on differences across racial and ethnic groups and by individual sexual identities.
To examine differences by sexual orientation in the lifetime prevalence of skin cancer among US adult females and males across racial and ethnic groups and by individual sexual identity.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used data from the Behavioral Risk Factor Surveillance System from January 1, 2014, to December 31, 2021, for US adults from the general population. Data were analyzed from December 1, 2023, to March 1, 2024.
Self-reported lifetime prevalence of skin cancer by sexual orientation. Age-adjusted prevalence and adjusted prevalence odds ratios (AORs) compared heterosexual and SM adults in analyses stratified by individual race.
Of 1 512 400 participants studied, 805 161 (53.2%) were heterosexual females; 38 933 (2.6%), SM females; 638 651 (42.2%), heterosexual males; and 29 655 (2.0%), SM males. A total of 6.6% of participants were Hispanic; 3.4%, non-Hispanic Asian, Pacific Islander, or Hawaiian; 7.5%, non-Hispanic Black; 78.2%, non-Hispanic White; and 4.3%, other race and ethnicity. Mean (SE) age was 48.5 (0.03) years (incomplete data for age of respondents ≥80 years). The lifetime prevalence of skin cancer was overall higher among SM males compared with heterosexual males (7.4% vs 6.8%; AOR, 1.16; 95% CI, 1.02-1.33), including specifically among Hispanic males (4.0% vs 1.6%; AOR, 3.81; 95% CI, 1.96-7.41) and non-Hispanic Black males (1.0% vs 0.5%; AOR, 2.18; 95% CI, 1.13-4.19) in analyses stratified by race and ethnicity. Lifetime prevalence rates were lower among SM females compared with heterosexual females among non-Hispanic White females (7.8% vs 8.5%; AOR, 0.86; 95% CI, 0.76-0.97) and were higher among Hispanic (2.1% vs 1.8%; AOR, 2.46; 95% CI, 1.28-4.70) and non-Hispanic Black (1.8% vs 0.5%; AOR, 2.33; 95% CI, 1.01-5.54) females in analyses stratified by race and ethnicity.
In this cross-sectional study of US adults, differences in the lifetime prevalence of skin cancer among SM adults compared with heterosexual adults differed across racial and ethnic groups and by individual sexual identity among both females and males. Both Hispanic and non-Hispanic Black and SM females and males had higher rates of skin cancer compared with their heterosexual counterparts. Further research addressing the individual factors contributing to these differences is needed to inform screening guidelines and public health interventions focused on these diverse, heterogeneous populations.
已发现性少数群体(SM)人群的皮肤癌发病率存在差异,但关于不同种族和族裔群体以及个体性身份之间差异的数据有限。
在跨种族和族裔群体以及按个体性身份检查美国成年女性和男性中,性取向与皮肤癌终生患病率之间的差异。
设计、地点和参与者:本横断面研究使用了 2014 年 1 月 1 日至 2021 年 12 月 31 日美国普通人群中来自行为风险因素监测系统的数据。数据分析于 2023 年 12 月 1 日至 2024 年 3 月 1 日进行。
通过性取向报告的皮肤癌终生患病率。在按个体种族分层的分析中,比较了异性恋和 SM 成年人的年龄调整患病率和调整后的优势比(AOR)。
在 1512400 名参与者中,805161 名(53.2%)为异性恋女性;38933 名(2.6%)为 SM 女性;638651 名(42.2%)为异性恋男性;29655 名(2.0%)为 SM 男性。共有 6.6%的参与者为西班牙裔;3.4%为非西班牙裔亚裔、太平洋岛民或夏威夷原住民;7.5%为非西班牙裔黑人;78.2%为非西班牙裔白人;4.3%为其他种族和族裔。平均(SE)年龄为 48.5(0.03)岁(80 岁及以上受访者的年龄数据不完整)。总体而言,SM 男性的皮肤癌终生患病率高于异性恋男性(7.4%比 6.8%;AOR,1.16;95%CI,1.02-1.33),包括特定种族和族裔的西班牙裔男性(4.0%比 1.6%;AOR,3.81;95%CI,1.96-7.41)和非西班牙裔黑人男性(1.0%比 0.5%;AOR,2.18;95%CI,1.13-4.19)。在按种族和族裔分层的分析中,与异性恋女性相比,SM 女性中非西班牙裔白种人的终生患病率较低(7.8%比 8.5%;AOR,0.86;95%CI,0.76-0.97),而西班牙裔(2.1%比 1.8%;AOR,2.46;95%CI,1.28-4.70)和非西班牙裔黑人(1.8%比 0.5%;AOR,2.33;95%CI,1.01-5.54)的终生患病率较高。
在这项对美国成年人的横断面研究中,与异性恋成年人相比,SM 成年人中皮肤癌终生患病率的差异因种族和族裔群体以及女性和男性的个体性身份而异。西班牙裔和非西班牙裔黑人和 SM 女性和男性的皮肤癌发病率均高于其异性恋同龄人。需要进一步研究导致这些差异的个体因素,以为这些不同的、异质的人群提供筛查指南和公共卫生干预措施。